best performing mid cap in november 2025

Olema Pharmaceuticals (OLMA) had the highest return in November 2025 by a mid-cap US stock, returning 214.7%.

ASSETMONTH% RETURN
Olema Pharmaceuticals (OLMA)
November 2025
214.67%
PACS (PACS)
November 2025
175.89%
Cogent Biosciences (COGT)
November 2025
147.51%
Terns Pharmaceuticals (TERN)
November 2025
100.07%
Haemonetics (HAE)
November 2025
63.03%
Alumis (ALMS)
November 2025
62.85%
McGraw Hill (MH)
November 2025
59.11%
Hycroft Mining (HYMC)
November 2025
53.95%
Kohl's (KSS)
November 2025
53.21%
Scholar Rock (SRRK)
November 2025
49.91%
Polibeli Group Ltd Class A Ordinary Shares (PLBL)
November 2025
47.82%
Brinker International (EAT)
November 2025
43.29%
Comstock Resources (CRK)
November 2025
42.87%
Edgewise Therapeutics (EWTX)
November 2025
42.45%
Aris Mining (ARMN)
November 2025
42.11%
Seaboard (SEB)
November 2025
40.9%
10X Genomics (TXG)
November 2025
37.6%
Teradata (TDC)
November 2025
37.49%
Compass (COMP)
November 2025
37.47%
Abercrombie & Fitch (ANF)
November 2025
37.15%
Orla Mining (ORLA)
November 2025
36.63%
Viridian Therapeutics (VRDN)
November 2025
36%
Baytex Energy (BTE)
November 2025
34.16%
Lifestance Health (LFST)
November 2025
32.65%
ZIM Integrated Shipping Services (ZIM)
November 2025
32.1%
Mid-cap stocks are treated as having a market cap between $2B and $10B.